We may soon be facing the end of the “antibiotic era.” The initial and seemingly unstoppable
success of antibiotics, the fruit of human ingenuity, has been countered by an escalation of …

… Acinetobacter baumannii is a leading cause of nosocomial … We mapped the global prevalence
of multidrug-resistant A. … , and hence it is challenging to define whether they are native …

Acinetobacter baumannii is an opportunistic nosocomial pathogen and one of the six most
important multidrug resistant microorganisms in hospitals worldwide. This human pathogen is …

… Acinetobacter baumannii (named in honor of the American bacteriologists Paul and Linda
Baumann) is a Gram-negative, multidrug-resistant (MDR) pathogen that causes nosocomial …

… Our study highlights the emerging challenges entailed in the WGS-powered epidemiological
surveillance of globally distributed clonal groups. Standardization is urgently required …

… In a global world with migration and increasing use of antimicrobials, multidrug-resistant
bacteria will continue to adapt and challenge our healthcare systems worldwide. …

… is a global challenge, it would … global scale. Further efforts, including potentially compulsory
surveillance and data gathering, are required in order to properly face this global challenge. …

… Acinetobacter baumannii (CRAB) has become one of the leading causes of healthcare-associated
infections globally… have been recognized as a global challenge because of its multiple…

… Acinetobacter baumannii is one such pathogen that has been … challenging hospital-acquired
pathogens as World Health Organization has listed carbapenem-resistant A. baumannii as …

… Antimicrobial resistance (AMR) represents a major challenge to global health. This … globally.
One of the key pathogens is the Gram-negative coccobacilli, Acinetobacter baumannii. It has …